20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
C3B BINDING POLYPEPTIDE
#602MEDICAMENT FOR TREATING CANCER, IMMUNOSTIMULANT, AND METHOD FOR SCREENING FOR ANTI-CANCER SUBSTANCE
#603Compositions and Methods for Degradation of Misfolded Proteins
#604MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS
#605METHODS FOR INDUCING CELL DIVISION OF POSTMITOTIC CELLS
#606C3B BINDING POLYPEPTIDE
#607ANTI-RNA VIRAL PHARMACEUTICAL COMBINATION THERAPY WITH APROTININ + anti-RNA DRUG
#608TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#609TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS
#610NUCLEIC ACID CONSTRUCTS AND USES THEREOF FOR TREATING SPINAL MUSCULAR ATROPHY
#611OVEREXPRESSION OF LEMD2, LEMD3, OR CHMP7 AS A THERAPEUTIC MODALITY FOR TAUOPATHY
#612Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#613USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS
#614ALGINATE HYDROGEL AND NEW COMPOSITION DERIVED THEREFROM FOR THE TREATMENT OF ECTOPIC CALCIFICATIONS
#615Modulation of an individual's gut microbiome to address osteoporosis and bone disease
#616COMPOSITIONS AND METHODS USING A COMBINATION OF AUTOPHAGY INDUCER AND HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY
#617Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)
#618HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE
#619CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#620TCF7L2 MEDIATED REMYELINATION IN THE BRAIN
#621TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF
#622Stabilized BCL9 peptides for treatment of aberrant Wnt signaling
#623NUTRITION FORMULATION
#624Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#625COMPOSITIONS AND METHODS FOR TREATING DIABETES, HYPERTENSION AND HYPERCHOLESTEROLEMIA
#626INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR
#627COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT
#628METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
#629METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION
#630MODIFIED KISSPEPTIN RECEPTOR AGONISTS FOR FATTY LIVER DISEASE
#631COMPOSITIONS, METHODS AND USES COMPRISING TENEURIN C-TERMINAL ASSOCIATED PEPTIDE -1 (TCAP-1) FOR ENHANCING MUSCLE PERFORMANCE
#632NRF2 Activator for Use in Treating Dilated Cardiomyopathies
#633NOVEL MUTANT BACTERIORHODOPSIN-LIKE-CHANNELRHODOPSIN ION CHANNEL
#634INHIBITION OF ENDOSOMAL TOLL-LIKE RECEPTOR ACTIVATION
#635Extracellular Vesicles and Compositions Thereof
#636Materials and methods for treating Friedreich's Ataxia
#637Compositions and methods for treating cancer
#638MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#639COMPOSITIONS AND METHODS FOR REGULATING LEUKOCYTE ADHESION
#640C-Type Natriuretic Peptides and Methods Thereof in Treating Cancer
#641Recombinant Human CC10 Protein for Treatment of Influenza, Ebola and Coronavirus
#642BAG3 METHODS AND USES FOR TREATMENT OF INFLAMMATION
#643RSPO1 PROTEINS AND THEIR USE
#644Hydrophilic Degradable Microspheres for Local Delivering of Glycopeptide Antibiotics and Polycationic Peptide Antibiotics
#645Probiotic to enhance an individual's skin microbiome
#646MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME
#647PRODUCTION OF RECOMBINANT LUBRICIN
#648METHOD OF TREATMENT OF CONGENITAL MYASTHENIC SYNDROME USING DOK7 GENE OR POLYPEPTIDE
#649EFFECTIVE TREATMENTS FOR VASCULAR ASSOCIATED MACULOPATHY, SEVERE MACULOPATHY, LATE-STAGE MACULOPATHY, AND ABERRANT CHORIOCAPILLARIS
#650ASSESSING AND TREATING BIOLOGICAL AGING
#651Saposin C pharmaceutical compositions and methods of treating cancer
#652METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#653COMPOSITION AND METHODS FOR TREATMENT OF PRIMARY CILIARY DYSKINESIA
#654ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)
#655Mutant Peptides And Methods Of Treating Subjects Using The Same
#656Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#657COMPOSITIONS AND METHODS RELATING TO ANTIVIRAL THERAPEUTICS
#658Administration of CEBP-Beta Antagonist and Methods of Use
#659COMPOSITIONS AND METHODS FOR TREATING ATRIAL FIBRILLATION
#660Topical application of CRISPR-modified bacteria to treat acne vulgaris
#661FLUID GEL COMPOSITIONS
#662MICRORNA-MEDIATED METHODS FOR REJUVENATING CNS GLIAL POPULATIONS
#663Peptide for Inducing Regeneration of Tissue and Use Thereof
#664TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
#665METHODS AND COMPOSITIONS FOR MODULATING ENDOTHELIAL CELL DYSFUNCTION
#666Methods and Compositions to Treat Vascular Leak
#667NEUROGENIC TISSUE NANOTRANSFECTION IN THE MANAGEMENT OF CUTANEOUS DIABETIC POLYNEUROPATHY
#668TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1)
#669COMPOSITIONS AND METHODS FOR TREATING SLC26A4-ASSOCIATED HEARING LOSS
#670MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY
#671METHOD FOR INDUCING GLIAL CELLS TRANSDIFFERENTIATION INTO FUNCTIONAL NEURONS, AND APPLICATION THEREOF
#672METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORS
#673INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS
#674IMMUNOTHERAPIES EMPLOYING SELF-ASSEMBLING VACCINES
#675KLF Induced Cardiomyogenesis
#676COMPOSITIONS AND METHODS FOR TREATING MYELIN DEFICIENCY BY REJUVENATING GLIAL PROGENITOR CELLS
#677GENE THERAPY OF NIEMANN-PICK DISEASE TYPE C
#678COMPOSITION AND METHODS FOR TREATMENT OF PRIMARY CILIARY DYSKINESIA
#679PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE, INCLUDING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT
#680METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTIONS
#681Method for Treating Lysosomal Storage Diseases with Histatin Peptides
#682PEPTIDE INHIBITORS OF GUANINE NUCLEOTIDE EXCHANGE FACTOR H-1
#683ISTHMIN 1 FOR TREATMENT OF LUNG INFLAMMATION
#684METHODS OF TREATING NASH AND COMPOSITIONS THEREFORE
#685COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER
#686COMPOSITIONS AND METHODS FOR TREATING NEOVASCULARIZATION AND ISCHEMIC RETINOPATHIES BY TARGETING ANGIOGENESIS AND CHOLESTEROL TRANSPORT
#687ANTIVIRAL COMPOSITIONS AND METHODS
#688BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES
#689METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#690COMPOSITIONS AND METHODS FOR TREATING CANCER
#691LNP COMPOSITIONS COMPRISING AN MRNA THERAPEUTIC AND AN EFFECTOR MOLECULE
#692ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#693TREATMENT OF AN ISCHEMIC HEART DISEASE
#694PEPTIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF A DISEASE CAUSED BY A VIRUS AFFECTING THE RESPIRATORY TRACT
#695IL-18 Binding Protein (IL-18BP) In Respiratory Diseases
#696INDUCTION OF PROLIFEROUS PANCREATIC ISLET PRECURSOR CELL-LIKE CELLS BY TRANSIENT EXPRESSION OF MYCL AND INDUCTION OF DIFFERENTIATION INTO INSULIN-POSITIVE CELLS
#697Method and system for reducing the likelihood of developing depression in an individual
#698HETEROCYCLIC GLP-1 AGONISTS
#699METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE
#700METHODS AND COMPOSITIONS COMPRISING BRD9 ACTIVATING THERAPIES FOR TREATING CANCERS AND RELATED DISORDERS
#701METHODS AND SYSTEMS FOR NONINVASIVE CONTROL OF BRAIN CELLS AND RELATED VECTORS AND COMPOSITIONS
#702RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE
#703USE OF CD83 IN COMBINATION THERAPIES
#704IMMUNOTHROMBOSIS IN COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME
#705METHODS AND COMPOSITIONS FOR TREATING FRAILTY
#706COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CARTILAGE-RELATED DISEASES OR SYMPTOMS, COMPRISING HAPLN1
#707COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS
#708TREATMENT OF ALT CANCERS
#709COMPOSITION AND METHODS FOR PREVENTING RADIATION INJURY AND PROMOTING TISSUE REGENERATION
#710USE OF CYP4V2 AND RDCVF IN THE MANUFACTURE OF MEDICAMENT
#711Reconstituted HDL formulation
#712NUTRITIONAL FORMULA
#713DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION
#714C-type natriuretic peptide variants to treat skeletal dysplasia in children
#715TREATING AUTOSOMAL DOMINANT BESTROPHINOPATHIES AND METHODS FOR EVALUATING SAME
#716Gene therapy for neurodegenerative disorders
#717Compositions and methods for treating cancer
#718Compositions and Methods for the Systemic Treatment of Arthritis
#719Topical application of to ameliorate barrier damage and inflammation
#720ENHANCED EFFICACY OF COMBINATION OF GEMCITABINE AND PHOSPHATIDYLSERINE-TARGETED NANOVESICLES AGAINST PANCREATIC CANCER
#721COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
#722Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions
#723PEPTIDES AND ADJUVANTS FOR AUGMENTATION OF FIBROBLAST THERAPY FOR CORONAVIRUS
#724SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH
#725Inhibition of beta-arrestin oligomerization in tauopathy
#726GLYCOTARGETING THERAPEUTICS
#727CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#728COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER
#729Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases
#730A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
#731METHOD OF ENHANCING AQUEOUS HUMOR OUTFLOW AND REDUCING INTRAOCULAR PRESSURE
#732MODIFIED COMPLEMENT PROTEINS AND USES THEREOF
#733NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#734RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
#735CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES
#736Compositions and methods for treating non-age-associated hearing impairment in a human subject
#737Use of SAA, rSAA or inhibitors of SAA in the treatment of dysregulated inflammation
#738Gene therapy for neurodegenerative disorders
#739TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS
#740COMPOSITIONS INCLUDING AMELOGENIN AND USES THEREOF
#741SEMG2 ANTIBODY AND USE THEREOF
#742IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#743EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS
#744PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS
#745Heat Substrate and/or Image Enhancement Compositions and Enhanced Tissue Ablation Methods
#746Triple combination antibody therapies
#747PROPHYLACTIC USES OF ANNEXIN A2
#748INHIBITION OF AUTISM SPECTRUM DISORDER USING DECOY ANTIGENS TO MATERNAL BRAIN-REACTIVE ANTIBODIES
#749PEPTIDES USEFUL IN PRESERVATION AND/OR RESTORATION OF FUNCTIONAL PANCREATIC ISLETS AND IN TREATING DIABETES
#750DAP12 constructs and their use to enhance DC vaccines and immunotherapies
#751METHODS AND COMPOSITIONS FOR GENERATING TYPE 1 VESTIBULAR HAIR CELLS
#752Translatable molecules and synthesis thereof
#753Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#754METHOD FOR PRODUCING STEM CELL WITH ENHANCED EFFICACY
#755USE OF LIPOSOMAL WNT COMPOSITIONS TO ENHANCE OSSEOINTEGRATION
#756Cellular reprogramming to reverse aging and promote organ and tissue regeneration
#757Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate Conditions
#758Method and system for reducing the likelihood of osteoporosis
#759Anti-tumor polypeptide Bax-BH3, fluorescent polymeric nanomicelle, preparation method and use thereof
#760IMMUNOMODULATING TUMOR NECROSIS FACTOR RECEPTOR 25 (TNFR25) AGONISTS, ANTAGONISTS, AND IMMUNOTOXINS
#761STERICALLY STABILIZED CARRIER FOR AEROSOL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL
#762METHODS OF TREATING RETINAL DISEASES
#763COMPOSITIONS AND METHODS FOR REGULATING SAS1R
#764METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR RESPECTIVE RECEPTORS
#765INHIBITING THE RNA METHYLTRANSFERASE METTL3 OR ITS INTERACTION WITH EIF3H TO SUPPRESS ONCOGENE TRANSLATION AND TUMORIGENESIS
#766NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS
#767Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein
#768Cellular fibronectin compositions
#769Adeno-Associated Virus Vector Delivery of Microrna-29 to Treat Muscular Dystrophy
#770Processes for making a cellular fibronectin composition
#771Dry Powder Formulations for Messenger RNA
#772METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
#773TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN
#774COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES COMPRISING CCR2
#775Heparin-Associated Polypeptides and Uses Thereof
#776USE OF GELSOLIN TO TREAT OR PREVENT LUNG INJURY AND DISEASE
#777NEURONAL VIABILITY FACTOR AND USE THEREOF
#778PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#779USE OF SUMF2 GENE AS A GENE THERAPY TARGET FOR PREVENTING AND/OR TREATING ALLERGIC ASTHMA ATTACK AND REDUCING AIRWAY HYPERRESPONSIVENESS
#780TREATMENT OF DISEASES INVOLVING MUCIN
#781Compositions and Methods for Inhibiting T Cell Exhaustion
#782COMPOSITIONS AND METHODS OF INDUCING DIFFERENTIATION OF A HAIR CELL
#783METHODS AND COMPOSITIONS FOR MODULATING PD1
#784Methods for treating COVID-19
#785Proteins with cardioprotective activity
#786PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#787METHODS OF MODULATING HAIR FOLLICLE STEM CELL QUIESCENCE BY MODULATING DERMAL NICHE ACTIVATOR GAS6
#788COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES
#789A composition for boosting the immune system
#790USE OF FRATAXIN FOR TREATING LEIGH SYNDROME, FRENCH CANADIAN TYPE
#791Method for treating individuals having cancer and who are receiving cancer immunotherapy
#792Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#793Method for treating type I diabetes with peptide-loaded dendritic cells
#794Method for treating multiple sclerosis with peptide-loaded dendritic cells
#795NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION
#796Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#797Recombinant Adeno-Associated Virus Delivery of Alpha-Sarcoglycan Polynucleotides
#798Polymer hydrogels for in vivo applications and methods for using and preparing same
#799VACCINE AND METHOD FOR TREATING CANCER
#800TREATMENT/PREVENTION OF DISEASE BY LINC COMPLEX INHIBITION
#801COMPOSITIONS AND METHODS FOR ENHANCING NEURO-REPAIR
#802Use of HDL in the prophylaxis of graft-versus-host disease
#803COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE
#804Adeno-Associated Virus Vector Delivery of Muscle Specific Micro-Dystrophin To Treat Muscular Dystrophy
#805LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
#806JNK INHIBITORS FOR USE IN TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS
#807TREATMENT AND PREVENTION OF PULMONARY INJURY
#808ROMO1-derived antimicrobial peptides including lysine substitution and variants thereof
#809Romo1-derived antimicrobial peptides and variants thereof
#810STABILIZED COLOSTRUM COMPOSITIONS
#811Use of Hsp70 as a regulator of enzymatic activity
#812Methods and Kit for Analyzing Responsiveness of Patients to CD19 Immunotherapy
#813METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#814TRANSGENIC NON-HUMAN ANIMAL CAPABLE OF CONTROLLING EXPRESSION OF TRANSCRIPTION FACTOR RP58
#815Cannabidiol (CBD) as Chemical for Treating Aging-related Degenerative Diseases and Promoting Health Aging
#816p63 inactivation for the treatment of heart failure
#817REGENERATION OF RETINAL GANGLION CELLS
#818USE OF FKBP-L POLYPEPTIDES AND NUCLEIC ACIDS FOR THE TREATMENT OF OBESITY
#819Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
#820Lipid formulations for delivery of messenger RNA
#821COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS OF USING THE SAME
#822Methods of treating hypertriglyceridemia or hypertriglyceridemia-related diseases
#823Methods of treating Kawasaki disease
#824COMPOSITIONS AND SYNERGISTIC METHODS FOR TREATING INFECTIONS
#825MELANOGENESIS DETECTION METHOD USING FAM86A
#826ANTIBODY CHEMICALLY INDUCED DIMERIZERS (AbCID) AS MOLECULAR SWITCHES AND USES THEREOF
#827METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#828Method for treating an individual suffering from bladder cancer
#829Prodrug Comprising a Drug-Linker Conjugate
#830Poly-Dioxanone Multi-Block Copolymer for Ocular Protein Delivery
#831THERAPEUTIC PEPTIDES
#832MATERIALS FOR DELIVERY OF TETHERABLE PROTEINS IN BONE IMPLANTS
#833METHODS OF TREATING FULMINANT VIRAL HEPATITIS
#834TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR
#835Kisspeptins to Predict and Treat Delayed Puberty
#836USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION
#837COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM
#838THERAPEUTIC PEPTIDES
#839PEPTIDES AND METHODS OF USE THEREOF IN TREATING UVEITIS
#840Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1
#841COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS
#842Immunotherapy against several tumors including lung cancer
#843Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
#844COMPOSITIONS AND METHODS TO POTENTIATE MUSCULOSKELETAL EFFECT OF ONE OR MORE ANABOLIC AMINO ACIDS
#845PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR
#846ALK7 antagonists and uses thereof
#847CYTOKINE MODULATION
#848Process and composition matter of nanoparticle formulation for systemic treatment of sepsis
#849TSG6 POLYPEPTIDE FRAGMENT FOR DRY EYE DISEASE
#850Methods and compositions for regenerating tissues
#851Immunotherapy against several tumors including lung cancer
#852Treatment of Heart Defects and Conditions in Pediatric Patients
#853TARGETING OF THE CYTOSKELETON AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE DISEASE
#854ANTICANCER AGENT AND METHOD FOR PREPARATION OF POROUS SILICA PARTICLE
#855METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENT
#856GASTRO-RESISTANT MICROENCAPSULATES, AND USES THEREOF TO STIMULATE IN-VIVO ILEAL GLP-1 RELEASE IN A MAMMAL
#857PERIVASCULAR LYSATES AND USES THEREOF
#858FCRN ANTAGONISTS AND METHODS OF USE
#859METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE
#860Treatment for Inflammatory Bowel Disease and Radiation-induced Intestinal Injury
#861MATERIALS AND METHODS FOR TARGETING REGULATORY T CELLS FOR ENHANCING IMMUNE SURVEILLANCE
#862Inhibition of cytokine-induced SH2 protein in NK cells
#863MPS MODIFIED PEPTIDES AND USE THEREOF
#864NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS
#865COMPOSITIONS AND METHODS FOR THE TREATMENT OF DBA USING GATA1 GENE THERAPY
#866COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME
#867ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY
#868AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY IN HUMANS
#869ANTIMICROBIAL THERAPY THROUGH THE COMBINATION OF PORE-FORMING AGENTS AND HISTONES
#870Immunotherapy against several tumors including gastrointestinal and gastric cancer
#871POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
#872INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#873HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS
#874RELEASE OF GROWTH FACTORS AT WOUND HEALING STAGES
#875PEPTOID-PEPTIDE HYBRID, NMEG-aCGRP, AND ITS USE IN CARDIOVASCULAR DISEASES
#876ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF
#877P21 Expressing Monocytes for Cancer Cell Therapy
#878COMPOSITION FOR PREVENTING, TREATING OR ALLEVIATING DIABETES, COMPRISING LGI3-DERIVED PEPTIDE AS AN ACTIVE INGREDIENT
#879THERAPEUTIC AGENT FOR DISEASE CAUSED BY DOMINANT MUTANT GENE
#880METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION
#881Treatment of Mood and Anxiety Disorders
#882Combination Therapy for Treating Disorders of the Ear
#883PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION
#884Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
#885METHODS OF TREATING INFLAMMATORY DISORDERS WITH MULTIVALENT FC COMPOUNDS
#886Peptide formulations and ophthalmic uses thereof
#887METHOD AND VEHICLE FOR DELIVERING AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#888WOUND CLOSURE ENHANCEMENT METHODS AND MATERIALS VIA MANIPULATION OR AUGMENTATION OF LIPIN-1
#889METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS
#890CAMKK1 AS A NOVEL REGENERATIVE THERAPEUTIC
#891COMPOSITIONS FOR USE IN THE TREATMENT OF INSULIN DEFICIENCY CONDITIONS
#892GALANIN- AND GALANIN RECEPTOR BASED COMPOUNDS FOR THE TREATMENT OF LIVER FIBROSIS
#893POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA
#894USE OF PCBP1 TO GENERATE INDUCED PLURIPOTENT STEM CELLS WHILE INHIBITING ONCOGENESIS
#895DEFERRED TREATMENT OF NERVE INJURIES
#896ORALLY DELIVERED LIPID NANOPARTICLES TARGET AND REVEAL GUT CD36 AS A MASTER REGULATOR OF SYSTEMIC LIPID HOMEOSTASIS WITH DIFFERENTIAL GENDER RESPONSES
#897COMPOSITION FOR USE IN A METHOD FOR PREVENTION OR TREATMENT OF MALTNUTRITION IN A SUBJECT SUFFERING FROM A CHRONIC INFLAMMATORY BOWEL DISEASES
#898METHODS OF TREATING CYTOKINE RELEASE SYNDROME
#899Sensorineural Hair Cell Differentiation
#900DENDRITIC CELL IMMUNOTHERAPY